How Francis was paid
$19.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Other | Total |
|---|---|---|---|---|---|---|
| Richard FrancisPresident and Chief Executive Officer | $1,700,000 | — | $11,999,970 | $4,827,405 | $641,334 | $19,168,709 |
| Eli KalifExecutive Vice President, Chief Financial Officer | $1,012,687 | — | $3,799,989 | $1,788,633 | $360,682 | $6,961,991 |
| Dr. Eric HughesExecutive Vice President, Global R&D and Chief Medical Officer | $829,231 | — | $3,749,983 | $1,569,817 | $149,902 | $6,298,933 |
| Christine FoxExecutive Vice President, US Commercial | $849,231 | — | $3,399,977 | $1,607,679 | $38,274 | $5,895,161 |
| Evan LippmanExecutive Vice President, Business Development | $496,923 | $700,000 | $4,899,975 | $1,074,808 | $50,303 | $7,222,009 |
What changed and why
- $19.2MCEO total compensation increased to $19,168,709 in 2025 from $15,518,947 in 2024.
- $17,258MRevenues reached $17,258 million, representing a 4% increase in U.S. dollars compared to 2024.
- $2,157MOperating income improved significantly to $2,157 million compared to an operating loss in 2024.
- 87%Advisory say-on-pay proposal received approximately 87% support at the 2025 annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.